Table 2 Distribution of immune-mediated diseases included in the study
No | Immune-mediated diseases included in the study | Number of cases (N = 235) | Percentage (%) |
|---|---|---|---|
1 | IgA nephropathy | 75 | 31.9 |
2 | Membranous nephropathy | 57 | 24.2 |
3 | Infection related glomerulonephritis | 45 | 19.1 |
4 | Lupus nephritis | 37 | 15.7 |
5 | Immune-complex mediated glomerulonephritis, unclassified | 7 | 2.9 |
6 | Ig Light chain cast nephropathy | 6 | 2.5 |
7 | Anti-glomerular basement membrane (Anti-GBM) disease | 5 | 2.1 |
8 | Ig Light chain deposition disease | 2 | 0.8 |
9 | AL Amyloidosis | 1 | 0.4 |